Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A retrospective study assessing effect of switching to Tenofovir Alafenamide on renal function in HIV infected patients.

Next Previous
Trial Profile

A retrospective study assessing effect of switching to Tenofovir Alafenamide on renal function in HIV infected patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Dec 2017

At a glance

  • Drugs Tenofovir alafenamide (Primary)
  • Indications HIV infections
  • Focus Adverse reactions

    • Most Recent Events

    • 06 Dec 2017 New trial record
    • 27 Oct 2017 Results presented at the 16th European AIDS Conference
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top